Alvotech (NASDAQ:ALVOW – Get Free Report) crossed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.29 and traded as low as $0.1501. Alvotech shares last traded at $0.1501, with a volume of 10,111 shares trading hands.
Alvotech Trading Down 49.1%
The firm has a fifty day simple moving average of $0.35 and a 200-day simple moving average of $0.29.
About Alvotech
Alvotech is a biotechnology company focused on developing and manufacturing biosimilar medicines. Biosimilars are biologic products designed to be highly similar to approved reference medicines and may provide additional treatment options in areas with significant healthcare costs. The company’s portfolio targets therapeutic categories including immunology, ophthalmology, oncology and other chronic conditions.
Alvotech operates an integrated business model that covers biosimilar research, cell-line development, process development, clinical testing and commercial-scale manufacturing.
Further Reading
- Five stocks we like better than Alvotech
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
